$MLNT MELINTA THERAPEUTICS, INC. /NEW/ Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MELINTA THERAPEUTICS, INC. /NEW/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in MELINTA THERAPEUTICS, INC. /NEW/. Find out how many shares they currently own, their value and whether they buy or sell their shares.
MELINTA THERAPEUTICS, INC. /NEW/ Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Aisling Capital II LP | 10% Owner | 3,293,060 | 9,879,180 | Feb 09 2012 | |||
| Bluth John D | EVP of IR and Corp Comm | 0 | 0 | Feb 27 2017 | |||
| Cammarata Sue | Chief Medical Officer | 4,000 | 12,000 | May 20 2019 | |||
| DOUGHERTY MICHAEL R | Director | 2,000 | 6,000 | Jan 05 2017 | |||
| DOUGHERTY MICHAEL R | Director | 0 | 0 | Jan 02 2015 | |||
| DOWNEY BRUCE | Director | 0 | 0 | Jun 12 2019 | |||
| Duffy Erin | Chief Scientific Officer | 4,000 | 12,000 | Jun 14 2018 | |||
| Estrem Paul | Chief Financial Officer | 10,000 | 30,000 | Jun 14 2018 | |||
| Fernandes Prabhavathi | President and CEO | 247,678 | 743,034 | Jan 05 2016 | |||
| Fernandes Prabhavathi | President and CEO | 219,289 | 657,867 | Jan 02 2015 | |||
| Ferro Kevin | Director | 0 | 0 | Jun 12 2019 | |||
| Galeota James JR | Director | 0 | 0 | Jun 12 2019 | |||
| GILL DAVID N | Director | 6,000 | 18,000 | Jun 12 2019 | |||
| GILL DAVID N | Director | 0 | 0 | Feb 06 2013 | |||
| GILL DAVID N | Director | 0 | 0 | Jan 02 2015 | |||
| GOLDSTEIN DOV A MD | Director | 99,900 | 299,700 | Mar 09 2017 | |||
| GOLDSTEIN DOV A MD | Director | 3,293,060 | 9,879,180 | Jan 05 2015 | |||
| GONZALO CECILIA | Director | 0 | 0 | Jun 14 2018 | |||
| Hahn Mark W | EVP and CFO | 0 | 0 | Feb 27 2017 | |||
| Hahn Mark W | EVP and CFO | 0 | 0 | Jan 22 2013 | |||
| Hahn Mark W | EVP and CFO | 0 | 0 | Jan 02 2015 | |||
| Intersouth Associates VI, LLC | 10% Owner | 963,502 | 2,890,506 | Mar 03 2016 | |||
| Intersouth Associates VI, LLC | 10% Owner | 1,345,558 | 4,036,674 | Feb 09 2012 | |||
| JOHNSON JOHN | Director | 0 | 0 | Feb 06 2013 | |||
| JOHNSON JOHN | Director | 10,000 | 30,000 | Jan 02 2015 | |||
| Johnson John H | Chief Executive Officer | 37,400 | 112,200 | Jul 02 2019 | |||
| Kent Richard S | Director | 15,392 | 46,176 | Jan 05 2017 | |||
| Kent Richard S | Director | 0 | 0 | Feb 06 2013 | |||
| Kent Richard S | Director | 0 | 0 | Jan 02 2015 | |||
| Koestler Thomas P | Director | 0 | 0 | Jun 12 2019 | |||
| Kong Garheng | Director | 2,830 | 8,490 | Jun 14 2018 | |||
| Kong Garheng | Director | 0 | 0 | Jan 02 2015 | |||
| Milligan Peter J | Chief Financial Officer | 0 | 0 | May 20 2019 | |||
| Moore David | Chief Commercial Officer | 1,500 | 4,500 | Feb 27 2017 | |||
| Moore David | Chief Commercial Officer | 0 | 0 | Jan 02 2015 | |||
| MORRIS I WISTAR III | Director | 496,286 | 1,488,858 | Mar 22 2012 | |||
| MORRIS I WISTAR III | 10% Owner | 744,533 | 2,233,599 | Aug 21 2012 | |||
| NEFF P SHERRILL | Director | 0 | 0 | Jan 02 2015 | |||
| NEFF P SHERRILL | Director | 3,262,154 | 9,786,462 | Feb 09 2012 | |||
| NEFF P SHERRILL | Director | 3,527,154 | 10,581,462 | Aug 01 2013 | |||
| NEFF SHERRILL P | Director | 2,527,154 | 7,581,462 | Oct 07 2016 | |||
| Oldach David W. | Chief Medical Officer | 1,100 | 3,300 | Feb 27 2017 | |||
| Quaker BioVentures II LP | 10% Owner | 3,527,154 | 10,581,462 | Aug 01 2013 | |||
| Vatera Healthcare Partners LLC | Director | 16,007,237 | 48,021,711 | Feb 26 2019 | |||
| Wechsler Daniel Mark | See Remarks | 50,000 | 150,000 | Jun 14 2018 | |||
| ZACCARDELLI DAVID | Director | 46,500 | 139,500 | Jun 12 2019 |